Equioxx®, the commercial formulation of generic firocoxib, is an FDA-approved COX-2 selective nonsteroidal anti-inflammatory medication used in horses in the context of pain and inflammation associated with osteoarthritis. It is available by prescription only and must be prescribed and monitored by a licensed veterinarian.
When inflammation contributes to pain and decreased mobility, veterinarians often consider nonsteroidal anti-inflammatory medications (NSAIDs) like Equioxx as part of a broader management approach.
Lameness and inflammatory joint disease are among the most common causes of reduced performance and chronic discomfort in horses, particularly in aging athletes and actively competing horses.
This article explains how Equioxx for horses works, when veterinarians prescribe it and how it compares to other equine NSAIDs within modern joint management.
Equioxx is a COX-2 selective nonsteroidal anti-inflammatory medication approved by the FDA for the control of pain and inflammation associated with osteoarthritis in horses. It is the brand name product labeled for equine use.
In clinical practice, Equioxx for horses is commonly considered for long-term inflammatory management in the context of chronic osteoarthritis.
Firocoxib has a long elimination half-life in horses and high plasma protein binding, characteristics that support sustained anti-inflammatory activity when used according to veterinarian-directed protocols. Medication selection, dosing and monitoring are determined solely by the prescribing veterinarian.
Equioxx for horses preferentially inhibits cyclooxygenase-2 (COX-2), the inducible enzyme upregulated during inflammation.
During inflammation, COX-2 expression increases within affected tissues, including synovial membranes. This enzyme drives the production of prostaglandins associated with:
By selectively inhibiting COX-2, firocoxib is associated with modulation of inflammatory prostaglandin synthesis within affected joints. For horses with osteoarthritis, this targeted mechanism is one factor veterinarians may consider as part of a broader, veterinarian-directed management strategy.
While COX-2 selectivity may influence gastrointestinal tolerability compared to nonselective NSAIDs, all NSAIDs carry potential risks. Safety depends on the individual horse, duration of use and concurrent therapies. Ongoing veterinary monitoring remains essential.
COX-1, which contributes to gastrointestinal mucosal protection and renal blood flow, is relatively spared.
This selective inhibition influences inflammatory prostaglandin production while maintaining important physiologic pathways.
Equioxx for horses is most commonly prescribed for conditions involving chronic inflammation of the joints and supporting structures.
Veterinarians most commonly prescribe Equioxx for:
Osteoarthritis in horses involves cartilage degeneration, synovial membrane inflammation and remodeling of subchondral bone. Inflammatory mediators within the joint capsule contribute to lameness, stiffness and decreased athletic performance.
Treatment decisions are individualized. A veterinarian evaluates the horse’s age, workload, concurrent medications, gastrointestinal risk factors and overall health before prescribing any NSAID.
Equioxx is more targeted than many traditional horse NSAIDs.
Several NSAIDs are available for horses, and each has a slightly different pharmacologic profile.
Understanding these differences can help guide conversations between you and your veterinarian when deciding how to approach short-term inflammation versus longer-term osteoarthritis management.
Medication selection is individualized and may depend on:
Only a veterinarian can determine the most appropriate anti-inflammatory strategy for a given horse.
Potential side effects of Equioxx and other NSAIDs in horses may include:
Risk may increase with dehydration, high-intensity exercise, concurrent NSAID administration or corticosteroid use.
Like all NSAIDs, Equioxx requires thoughtful veterinary oversight, particularly when used for ongoing osteoarthritis management. Periodic physical examinations and laboratory monitoring may be recommended depending on treatment duration and patient risk factors.
Because this is a prescription medication, veterinarians determine appropriate dosing, duration and monitoring intervals.
Important Note: Equioxx should not be administered alongside other NSAIDs or corticosteroids unless explicitly directed by a veterinarian.
Yes—FDA-approved generic firocoxib products are also available by prescription.
Equioxx is the FDA-approved commercial formulation of firocoxib for horses. These commercial products undergo regulatory review for safety, efficacy and manufacturing quality. For most horses, commercially available formulations provide appropriate strengths and dosage forms to support veterinarian-directed therapy.
As a full-service veterinary pharmacy, Mixlab dispenses FDA-approved commercial medications including Equioxx and generic firocoxib. We coordinate directly with your veterinarian to ensure accurate prescription fulfillment and reliable delivery.
Equioxx is prescribed by veterinarians to control pain and inflammation associated with osteoarthritis and other inflammatory musculoskeletal conditions.
It is a COX-2 selective NSAID intended to reduce inflammatory prostaglandin production.
Yes. Equioxx® is a brand-name product containing firocoxib and is FDA-approved for use in horses.
FDA-approved generic versions containing the same active ingredient are also available by prescription.
Safety depends on the individual horse, concurrent medications and duration of therapy. A veterinarian determines which NSAID is most appropriate based on clinical factors. Firocoxib has a different mechanism due to COX-2 selectivity.
Yes. Equioxx and all forms of firocoxib are prescription medications and must be prescribed by a licensed veterinarian following appropriate examination and evaluation.
Equioxx should not be administered with other NSAIDs or corticosteroids unless explicitly directed by a veterinarian, as concurrent use may increase the risk of adverse effects. Your veterinarian will review your horse's full medication history before prescribing any NSAID to evaluate potential interactions.
Equioxx for horses is an FDA-approved COX-2 selective NSAID used in horses in the context of pain and inflammation associated with osteoarthritis. Its COX-2 selective pharmacologic profile provides a targeted approach to inflammatory pathways while requiring the same careful veterinary oversight as other NSAIDs.
Is your horse experiencing lameness or joint-related discomfort? Talk to your veterinarian about whether Equioxx (or generic firocoxib) is appropriate.
Once prescribed, you can order Equioxx or generic firocoxib here through Mixlab. Our equine pharmacy coordinates directly with your veterinarian to ensure accurate fulfillment and reliable delivery to your doorstep.